Tag: #Global Trends

Key Development Merck has announced that Keytruda (pembrolizumab) became the first PD-1 inhibitor to demonstrate a clinically meaningful benefit as... Read more

Key Development The Oncology Institute (NASDAQ: TOI) disclosed that its Chief Medical Officer (CMO), Dr. Yale D. Podnos, sold company... Read more

Key Development Voyager Technologies has signed a memorandum of understanding (MOU) with Geisinger, one of the largest integrated health systems... Read more

Key Development A recent poisoning incident involving an elderly patient has drawn attention to a much larger issue than a... Read more

Key Development Brazilian retailer Assaí Atacadista has expanded into the pharmacy business, opening its first in-store pharmacy in the state... Read more

Key Development Johnson & Johnson has reported quarterly financial results that exceeded Wall Street expectations, supported primarily by the continued... Read more

Key Development The European Commission has approved Novo Nordisk's once-daily oral Wegovy for chronic weight management, making it the first... Read more

Key Development Leadership transitions within major public health agencies rarely attract widespread attention. However, the nomination process for the next... Read more

Key Development Eli Lilly is reportedly nearing an agreement to acquire AtaiBeckley, a biotechnology company developing psychedelic-based therapies for mental... Read more